|
|
H2022/CTD5595/2264ER
|
MYDEKLA 60
|
DACLATASVIR DIHYDROCHLORIDE
|
SURGILINKS LTD
|
Registered
|
Details →
|
|
|
1275
|
MYDRIACYL 1% OPHTHALMIC PREPARATION
|
TROPICAMIDE
|
PAN PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
CTD1659
|
MYDROX CAPSULES
|
CEFADROXIL USP
|
ZIKE CORPORATION LTD
|
Registered
|
Details →
|
|
|
H2025/CTD11235/21046
|
MYELOPAST 10
|
LENALIDOMIDE DIMETHYL SULPHOXIDE
|
MSN LABORATORIES PVT LTD
|
Registered
|
Details →
|
|
|
H2025/CTD11256/21047
|
MYELOPAST 25
|
LENALIDOMIDE DIMETHYL SULPHOXIDE
|
MSN LABORATORIES PVT LTD
|
Registered
|
Details →
|
|
|
H2024/CTD7458/14642
|
MYENERVE
|
GABAPENTIN USP AND METHYLCOBALAMINE IH
|
KRISHNA CHEMISTS LTD
|
Registered
|
Details →
|
|
|
15967
|
MYFORTIC TABLETS 180MG
|
MYCOPHENOLATE SODIUM
|
NVS KENYA LTD
|
Registered
|
Details →
|
|
|
16124
|
MYFORTIC TABLETS 360MG
|
MYCOPHENOLATE SODIUM
|
NVS KENYA LTD
|
Registered
|
Details →
|
|
|
H2019/CTD7319/14374
|
MYGESTY INJECTION
|
MEDROXYPROGESTERONE ACETATE
|
SAI PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
20077
|
MYGRA 100
|
SILDENAFIL CITRATE USP
|
UNISEL LTD
|
Registered
|
Details →
|
|
|
H2021/CTD7596/14779
|
MYHEP (SOFOSBUVIR TABLETS 400 MG)
|
SOFOSBUVIR
|
SURGILINKS LTD
|
Registered
|
Details →
|
|
|
H2021/CTD7595/14777
|
MYHEP ALL (SOFOSBUVIR AND VELPATASVIR TABLETS 400 MG/ 100 MG)
|
SOFOSBUVIR AND VELPATASVIR
|
SURGILINKS LTD
|
Registered
|
Details →
|
|
|
H2021/CTD5924/1926ER
|
MYHEP DVIR (DACLATASVIR AND SOFOSBUVIR FILM-COATED TABLETS 60 MG/400 MG)
|
DACLATASVIR AND SOFOSBUVIR FILM-COATED TABLETS 60 MG/400 MG.
|
SURGILINKS LTD
|
Registered
|
Details →
|
|
|
14404
|
MYLERAN
|
BUSULPHAN
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
H2018/CTD4601/411ER
|
MYLOVASC 2.5MG TABLETS
|
S-AMLODIPINE BESILATE
|
WESSEX PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2018/CTD4601/411ER/R1
|
MYLOVASC 2.5MG TABLETS
|
S-AMLODIPINE BESILATE
|
PRISMA PHARMA FZE
|
Retained
|
Details →
|
|
|
H2018/CTD4602/412ER
|
MYLOVASC 5 MG
|
S-AMLODIPINE BESILATE
|
PHARMA SPECIALITIES LTD
|
Registered
|
Details →
|
|
|
CTD 4602
|
MYLOVASC 5 MG TABLETS
|
S-AMLODIPINE BESILATE
|
WESSEX PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
CTD 4602/R1
|
MYLOVASC 5 MG TABLETS
|
S-AMLODIPINE BESILATE
|
PRISMA PHARMA FZE
|
Retained
|
Details →
|
|
|
H2018/CTD4602/412ER/R1
|
MYLOVASC 5 MG TABLETS
|
S-AMLODIPINE BESILATE
|
PRISMA PHARMA FZE
|
Retained
|
Details →
|